Because Glyteer treatment inhibits IL-4/Stat6 signaling, in addition to its anti-inflammatory property, the utilization of Glyteer is thought to be more beneficial, especially in the treatment of AD. This evidence concerns the gene STAT6 and Alzheimer disease.